UPDATE 2-Alcobra to stop testing sole drug for ADHD after study fails

Jan 17 (Reuters) - Alcobra Ltd said it would

abandon evaluating its only experimental drug to treat attention

deficit hyperactivity disorder (ADHD), after a failed late-stage

study, wiping away more than half the company's value before the

bell on Tuesday.

Read more